Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, and Chronic Myeloid Leukemia Treatments.
Post-transplant Cyclophosphamide (PTCy) for HLA-Matched Hematopoietic Stem Cell Transplant (HCT) in Pediatric and Young Adult Patients with Hematologic Malignancies
Murine gut microbiota dysbiosis via enteric infection modulates the foreign body response to a distal biomaterial implant
Murine gut microbiota dysbiosis via enteric infection modulates the foreign body response to a distal biomaterial implant
Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2
Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.
Trainee-led Engagement of the Care Team Improves Application of an Institutional Blood Culture Clinical Decision Algorithm to Pediatric Oncology Inpatients: A Single-institution Quality Improvement Project.
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed <i>ALK</i> F1174L-mutated neuroblastoma.
Consensus Recommendations for Blood Culture Use in Critically Ill Children Using a Modified Delphi Approach.
Microbial Sharing between Pediatric Patients and Therapy Dogs during Hospital Animal-Assisted Intervention Programs.
Reducing and Sustaining Duplicate Medical Record Creation by Usability Testing and System Redesign.
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.
Understanding CancelRx: Results of End-to-End Functional Testing, Proactive Risk Assessment, and Pilot Implementation.
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
Longitudinal diffusion MRI for treatment response assessment: Preliminary experience using an MRI‐guided tri‐cobalt 60 radiotherapy system
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis
Hepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis
Implementation of a Central Line Maintenance Care Bundle in Hospitalized Pediatric Oncology Patients
Assessment of Environments for Mars Science Laboratory Entry, Descent, and Surface Operations